Les conférences seront en anglais. Nous vous présentons ici le programme en anglais. Pour tout retrouver dans la langue de Molière, il faudra lire les comptes-rendus que www.allergique.org fera.

Vous trouverez en fin de page tous les renseignements pour vous inscrire au congrès et réserver un hôtel.

Lundi 27 Juin

Plenary Session

– 10.30 - 12.00

The Good and the Bad Immune Response Cytokines and antibody production
TADAMITSU KISHIMOTO, Osaka, Japan

• Regulatory T cells, do they exist ?
  SERGIO ROMAGNANI, Firenze, Italy
• The good and the bad IgE response
  RAIF GEHA, Boston, United States
• Tolerance
  ROLF ZINKERNAGEL, Zürich, Switzerland

Symposia

– 08.30 - 10.00

Asthma Pathophysiology

• Epithelial cells in asthma
  STEPHEN HOLGATE, Southampton, United Kingdom
• Allergic inflammation and airway remodelling
  WALTER CANONICA, Genova, Italy
• Angiogenesis in airways
  TAKEMASA NAKAGAWA, Kawasaki, Japan
• COPD vs asthma
  KLAUS RABE, Leiden, The Netherlands

– 08.30 - 10.00

Urticaria and Angioedema

• Angioedema : new aspects in pathophysiology and therapy
  ALLEN KAPLAN, Charleston, United States
• Hereditary angioneurotic edema : subtypes
  KONRAD BORK,Mainz, Germany
• Chronic urticaria and autoimmunity
  MARTA FERRER, Pamplona, Spain
• Chronic urticaria : management program
  BETTINA WEDI, Hannover, Germany

- 13.30 - 15.00

Epidemiology (Global Trends in Allergy)

• Allergy in the Americas
  CARLOS BAENA-CAGNANI, Cordoba, Argentina
• ISAAC in Asia
  CHRISTOPHER LAI, Hong Kong, China
• The European asthma cohort
  PETER BURNEY, London, United Kingdom
• Allergy in Africa
  JOSEPH ODHIAMBO, Kenya (TBC)
• Trends and risk factors in allergy development
  ERIKA VON MUTIUS, Munich, Germany

15.30 - 17.00

Allergens

• Usefulness of recombinant allergens in clinics
  RUDOLF VALENTA, Vienna, Austria
• Allergen extracts in therapy
  RONALD VAN REE, Amsterdam, The Netherlands
• Bioengineering of allergens, e.g. peanut
  WESLEY BURKS, Durham, United States
• Hypoallergenic grass (genetically modified allergens)
  GERMAN SPANGENBERG, Bundoora, Australia

15.30 - 17.00

Infection and Allergy

• Bacterial infection and allergy
  ECKARD HAMELMANN, Berlin, Germany
• Viral infection and allergy
  NIKOLAOS PAPADOPOULOS, Athens, Greece
• Fungal infection and allergy
  THOMAS PLATTS-MILLS, Charlottesville,
  United States
• Parasites and allergy
  PETER LE SOUEF, Perth, Australia

Company Sponsored Symposia

– 13.15 - 15.00

Managing Specific Allergy

• Progressing the Quality Perspective
  ALK-Abelló

– 15.15 - 17.00
Are All Antihistamines the Same ?
UCB

Workshops

– 08.30 - 10.00

How do Allergens Look ? What can we learn from the Molecular Nature of Allergens ?

• Aspergillus allergens
  RETO CRAMERI, Davos, Switzerland
• Mite allergens
  WAYNE THOMAS, West Perth, Australia
• The major allergen of cladosporium herbarum
  MICHAEL BREITENBACH, Salzburg, Austria
• Shrimp allergens
  SAMUEL LEHRER, New Orleans, United States
• Bee venom allergens
• Cat allergens
  HANS GRÖNLUND, Stockholm, Sweden

– 13.30 - 15.00

Aerobiology

• Longer pollen seasons in Europe
  SIEGFRIED JÄGER, Vienna, Austria
• Pollen in the mediterranean climate
  GENNARO D’AMATO, Naples, Italy
• Mould counts : how reliable are they ?
• Grass pollen allergens
  ENRIQUE FERNANDEZ-CALDAS, Madrid, Spain

– 13.30 - 15.00

Immune Response to Microbes, Drugs :

• Role of Autoimmune Reactions ?
  Autoimmune phenomena in chagas infection
  PA REYEZ-LOPEZ, Colima, Mexico (TBC)
• Dermatitis and immune reactions against fungi :
  protective or harmful ?
  RICARDO GALIMBERTI, Buenos Aires, Argentina
• Desmosomal proteins as autoantigens
• Complement-mediated diseases
  AMODIO FRANK, Evansville, United States (TBC)
• New diagnostic approaches in LE
  MICHAEL MEURER, Dresden, Germany
• Drug-induced pemphigus vulgaris
  SARAH BRENNER, Tel Aviv, Israel

– 15.30 - 17.00

Allergens in the Farmhouse :

• Are There Allergic Farmers ? Allergens from cattle
  HORST MÜSKEN, Lippsringe, Germany
• Storage and predator mites : how they live and how they feed ?
  JÖRG-THOMAS FRANZ, Paderborn, Germany
• Mite allergen nature
  HENNING LØWENSTEIN, Horsholm, Denmark (TBC)
• Bloomia allergens
  LEE BEE WAH, Singapore, Singapore
• Farmers’ lung

– 15.30 - 17.00

Allergy and Pregnancy

• Antiallergic treatment in pregnancy
• In-utero shaping of immune response
  ZSOLT SZEPFALUSI, Vienna, Austria
• Skin rashes in pregnancy : what to do ?
  SAROLTA KARPATI, Budapest, Hungary
• Active allergy prevention strategies during pregnancy

15.30 - 17.00

Multiple Chemical Sensitivity/Eco- Syndrome : Does it Exist and How Do We Manage ?

• Clinical aspects of MCS
  EMIL BARDANA, Portland, United States
• Psychology of MCS
• Allergological findings in Eco-syndrome
  BERNADETTE EBERLEIN-KÖNIG,Munich, Germany
• Diagnostic approaches
  ANDREAS BIRCHER, Basel, Switzerland
• Immunological findings in MCS

---

Mardi 28 Juin

Plenary Session

– 10.30 - 12.00

Gene-Environment Interaction in Allergy

• Genetic basis of atopy and asthma
  EUGENE BLEECKER, Winston-Salem, United States
• Infections, allergens and mucosal tolerance
  DALE UMETSU, Stanford, United States
• TLR, LPS and allergy
  ROGER LAUENER, Zürich, Switzerland
• Atmospheric pollution, pollen and allergy
  HEIDRUN BEHRENDT, Munich, Germany

– EAACI General Assembly
12.00 - 13.15

Symposia

– 08.30 - 10.00

Genetics of Allergy

• Innate immunity and atopy - common genetic elements ?
  FERNANDO MARTINEZ, Tucson, United States
• Cytokine clusters in the genome
  LANNY ROSENWASSER, Denver, United States
• The molecular basis of atopic dermatitis
  YOUNG-AE LEE, Berlin, Germany
• Whole genome scans versus candidate gene analysis - what is the best approach for the future ?
  JUHA KERE, Helsinki, Finland

– 08.30 - 10.00

Environment Pollution and Allergy

• Tropical climate and allergy development
  LUISA KARLA ARRUDA, Ribeirão Preto, Brazil
• Atmospheric particles and health
  BERT BRUNEKREEF, Utrecht, The Netherlands
• Smoking and allergy development
  KARIN C. LØDRUP CARLSEN, Oslo Norway
• Perspectives of environmental research regarding allergy
  HILLEL KOREN, Chapel Hill, United States

– 13.30 - 15.00

Hygiene and Allergy

• Critical remarks to the hygiene hypothesis
  CHARLES K. NASPITZ, São Paulo, Brazil
• Indoor environment
  SUSANNE LAU, Berlin, Germany
• Infection and allergy
  PAOLO MATRICARDI, Geneva, Switzerland
• Vaccination and allergy
  HANS C RUMKE, Rotterdam, The Netherlands

– 13.30 - 15.00

Asthma Therapy

• Immunomodulation in asthma
  BARRY KAY, London, United Kingdom
• Bronchodilatory treatment
  PAUL POTTER, Cape Town, South Africa
• Asthma management
  RONALD DAHL, Aarhus, Denmark
• Treatment of acute severe asthma attack
  MICHAEL KALINER, Chevy Chase, United States

– 13.30 - 15.00

Food Allergy

• Food allergy : from sensitisation to prevention
  CARSTEN BINDSLEV-JENSEN, Odense, Denmark
• In-vitro monitoring of food allergy
• Hypoallergenic formula : the GINI study
  ANDREA VON BERG,Wesel, Germany
• Allergy to "gene modified food"

– 15.30 - 17.00

Occupational Allergy

• Occupational skin allergy
  WERNER ABERER, Graz, Austria
• Occupational asthma
  JOAQUIN SASTRE, Madrid, Spain
• Immunotherapy in occupational allergy
  SANTIAGO QUIRCE, Madrid, Spain
• Occupational allergy in food industry
  MOHAMED FAREED JEEBHAY, Cape Town, South Africa

Company Sponsored Symposia

– 08.30 - 10.15

Improving the Lives of Patients with Allergies
Aventis

– 13.15 - 15.00

Even More Lessons from the IgE Antibody System
Pharmacia Diagnostics

– 15.15 - 17.00
Anti-IgE : Addressing the Unmet Need in Inadequately Controlled Severe Allergic Asthma
Novartis

Workshops

– 08.30 - 10.00

Controversies in Paediatric Allergy I :

• Hygiene Hypothesis : Does it Apply Worldwide ? Protobiotics and hygiene hypothesis
  Vaccination strategies and allergy
  CHRISTOPH GRÜBER, Berlin, Germany
• Epidemiology of atopic diseases in Mexico
  JOSE HUERTA-LOPEZ, Mexico City, Mexico
• Atopic eczema in the jungle of Papua-New-Guinea
• Pertussis vaccination and infection : role in development of allergy and asthma
  URSULA KRÄMER, Düsseldorf, Germany

– 08.30 - 10.00

ASA Idiosyncrasy : After the Introduction of COX-2-Inhibitors, is it Still a Problem ?

• Genetics of ASA-asthma
  MAREK L. KOWALSKI, Lodz, Poland
• Pathophysiology of aspirin asthma
  ANDRZEJ SZCZEKLIK, Krakow, Poland
• NSAID hypersensitivity : diagnostic approaches
  MARIA SANZ, Pamplona, Spain
• Adaptive deactivation in ASA hypersensitivity
• Role of salicylate-free diets ?

– 08.30 - 10.00
Photo Allergy and Photosensitization : How Does UV Light Trigger it and What Can We Do Against it ?

• Practical problems with photopatch test procedures
  ERHARD HOELZLE, Oldenburg, Germany
• "Sun allergy" (polymorphic light eruption), what is the elicitor ?
  KEVIN D. COOPER, Cleveland, United States (TBC)
• Mechanisms of photosensitization
  HERBERT HOENIGSMANN, Vienna, Austria
• UV affecting the immune response towards tolerance
• UV can inhibit mast cell responses
  LAJOS KEMENY, Szeged, Hungary

– 13.30 - 15.00

How Important are CD8 + T Cells in Allergy ?

• T cell receptor function
• T cells and epithelial apoptosis
  MÜBECCEL AKDIS, Davos, Switzerland
• CD8 cells as effector cells in allergy
  MIKE KEMENY, London, United Kingdom (TBC)
• CD8 cells in hyposensitization
  MARTIN MEMPEL, Munich, Germany
• CD8 cells in contact dermatitis
• Recovery of physiological balance of Th1/Th2 : Conversation of allergic response to immune response by allergotropines
  RAKHIM KHAITOV, Moscow, Russia

– 15.30 - 17.00

How Useful are Animal Models ?

• Murine models of atopic eczema
  GEORG STINGL, Vienna, Austria
• Novel mouse mutants with severe combined immunodeficiencies generated by ENU mutagenesis
  THILO JAKOB, Munich, Germany
• Expression of neurotrophins in a house model of allergic airway inflammation
  ANDREAS NOCKHER, Marburg, Germany
• Models for pre/postnatal sensitization
  UDO HERZ, Kirchhain, Germany
• Humanized mouse models
  CATHERINE DUEZ, Lille, France

– 15.30 - 17.00

Drug Allergy : Practical Problems

• Additives in drugs as elicitors of anaphylaxis
  TORSTEN ZUBERBIER, Berlin, Germany
• Management of radiographic contrast media reactions
  KNUT BROCKOW, Munich, Germany
• Practical problems in diagnosis of drug allergy
• "Hyposensitization" in drug allergy
  TIMOTHY SULLIVAN, Atlanta, United States (TBC)
• Beta lactam cross-reactivity, when is it safe to give a cephalosporin to a penicillin-allergic patient
  MARIA J TORRES, Malaga, Spain

---

Mercredi 29 juin

Plenary Session

– 10.30 - 12.00

Cells in Allergy and How They React

• Introduction into the pathophysiology of allergy
  ANTHONY J. FREW, Southampton, United Kingdom
• Chemokines and allergy
  ALBERTO MANTOVANI, Milano, Italy
• T cell apoptosis and autoimmunity
  PETER KRAMMER, Heidelberg, Germany
• Signal transduction
  JOHANN DEISENHOFER, Dallas, United States

Symposia

– 08.30 - 10.00

T Cells in the Centre of the Immune Response

• T cell fitness
  ANTONIO LANZEVECCHIA, Bellinzona, Switzerland
• T regulatory cells in immunotherapy
  KURT BLASER, Davos, Switzerland
• T cells and eosinophils
  DOUGLAS ROBINSON, London, United Kingdom
• T cells in drug allergy
  WERNER PICHLER, Bern, Switzerland

– 08.30 - 10.00

Mediators

• Mast cell proteases
  RICHARD L. STEVENS, Boston, United States
• Cardiac mast cells
  GIANNI MARONE, Naples, Italy
• Leukotriene metabolism
  SVEN-ERIK DAHLÉN, Stockholm, Sweden
• Chemokines in asthma
  KOUJI MATSUSHIMA, Tokyo, Japan

– 13.30 - 15.00

Eosinophils

• Eosinophil activation by danger signals
  MONIQUE CAPRON, Lille, France
• Eosinophil-derived indoleamine 2,3-dioxygenase and Th2 immune selection
  REDWAN MOQBEL, Edmonton, Canada
• Eosinophils in inflammation
  BRUCE BOCHNER, Baltimore, United States
• HES pathophysiology
  HANS-UWE SIMON, Bern, Switzerland

– 13.30 - 15.00

Atopic Eczema

• S. Aureus in atopic eczema
• Role of food allergy in atopic eczema
  THOMAS WERFEL, Hannover, Germany
• Neuropeptides in atopic eczema
  ALBERTO GIANNETTI, Modena, Italy
• Management of infantile eczema
  JORGE MASPERO, Buenos Aires, Argentina

– 13.30 - 15.00

Non-injective Immunotherapy

• Mucosal tolerance in infants
  PATRICK HOLT, Perth, Australia
• Mechanisms of sublingual tolerance induction
  THOMAS BIEBER, Bonn, Germany
• Oral immunotherapy with allergens
  ERIKA JENSEN-JAROLIM, Vienna, Austria
• Critical evaluation of SLIT with aeroallergens
  HANS-JØRGEN MALLING, Copenhagen, Denmark

Company Sponsored Symposia

– 08.30 - 10.15

• Allergic Rhinitis and Asthma : Two Diseases with A Common Link
  Merck Sharp & Dohme

– 13.15 - 15.00

• Expansion and Consolidation - the Unfolding Trends in Respiratory Health
  Schering-Plough

– 15.15 - 17.00

• Defining the Role of ICS Monotherapy in the Management of Asthma
  ALTANA Pharma

Workshops

– 08.30 - 10.00

Beneficial and Harmful Effects of Infection Regarding Allergic Diseases

• RSV, allergy and asthma in mice
  SHYAM S. MOHAPATRA, Tampa, United States
• Viral infection as exacerbator of human asthma
  GERHARD SCHULTZE-WERNINGHAUS/
  GERNOT ROHDE, Bochum, Germany
• "Infect asthma", is there a role for bacterial vaccines ?
  VICTOR MOSHKEVITCH, Almaty, Kazakstan
• Helicobacter pilori and allergy
  NELLA PREVETE, Roccarainola, Italy (TBC)
• Probiotics and allergy prevention
  BENGT BJÖRKSTEN, Stockholm, Sweden
• Bifidobacteria in the gut
  MASASHI SUZUKI, Oita, Japan (TBC)
• Eczema herpeticum, role of dendritic cells
  ANDREAS WOLLENBERG, Munich, Germany

– 08.30 - 10.00

Open Questions in Irritant Contact Dermatitis

• Irritant versus contact dermatitis
• Does nickel sensitization produce loosening of implants ?
  PETER THOMAS, Munich, Germany
• New causes of irritant dermatitis
• Contact dermatitis to cosmetics
  HOWARD I. MAIBACH, San Fransisco, United States (TBC)
• New barrier protection creams

– 13.30 - 15.00

Is Absolute Avoidance of a Food Allergen Essential ? The Concept of Threshold Levels in Food Allergy

• The concept of threshold, why it is important
  SUSAN HEFLE, Lincoln, United States
• Correlations between threshold levels and SPT and RAST
  DENISE-ANNE MONERET-VAUTRIN, Nancy, France
• Threshold levels in childhood
  FABIENNE RANCÉ, Toulouse, France
• Analytical methods for traces of hidden allergens : Potential and limitations
  STEPHAN VIETHS, Langen, Germany

– 13.30 - 15.00

How Important is Mite Allergen Cross- Reactivity in Clinical Practice ?

• Tropomyosin as basis of mite cross reactivity in clinical practice
  JUDITH WOODFOLK, Charlottesville, United States
• Tropical mites in the southern hemisphere
  JOÃO FERREIRA DE MELLO, Saõ Paulo, Brazil
• Bloomia tropicalis cross-reactivity to other mites
  FOOK-TIM CHEW, Singapore, Singapore
• Storage mite cross-reactivity to house dust mite
  MARIANNE VAN HAGE-HAMSTEN, Stockholm, Sweden
• How does cross-reactivity influence mite allergen detection ?
  GABRIELLE PAULI, Strasbourg, France

– 15.30 - 17.00

Dendritic Cells

• Plasmocytoid DC in allergic contact and atopic dermatitis
  NATALIJA NOVAK, Bonn, Germany
• DC, prostanoids and allergy revisited
  FRANCOIS TROTTEIN, Lille, France
• Pollen-associated lipid mediators (PALMs) modulate dendritic cell function
  CLAUDIA TRAIDL-HOFFMANN, Munich, Germany
• DC, leukotrienes and allergic asthma
• Virus effects on DC in allergic asthma
• Dendritic cells in mycobacterial infection
  LEOPOLDO FLORES-ROMO, Mexico City, Mexico

– 15.30 - 17.00

Occupational Hand Dermatitis : What Can We Do for Prevention ?

• Causes and prevention of irritant contact dermatitis
  THOMAS L. DIEPGEN, Heidelberg, Germany
• In vitro models for prediction of irritancy
  PHIL BOTHAM, Macclesfield, United Kingdom
• What makes a chemical a contact allergen ?
• Differential diagnosis of hand and foot dermatitis

– 15.30 - 17.00

Hot Topics in Allergen-Specific Immunotherapy

• Prevention of life-threatening reactions
  EMILIO ALVAREZ-CUESTA, Madrid, Spain
• Practical management of ASIT
  ERKKA VALOVIRTA, Turku, Finland
• Progress in allergen standardization
• Recombinant allergens
  FATIMA FERREIRA, Salzburg, Austria
• Duration of ASIT
  ROBYN O’HEHIR, Melbourne, Australia
• M. vaccae as adjuvant in ASIT
  ISIL BARLAN, Istanbul, Turkey

– 15.30 - 17.00

Eosinophilic Inflammation : How to Deal With it ?

• Hypereosinophilic syndrome : molecular basis, malignancy or harmless proliferation ?
• IL-5, an eosinophilic cytokine, production from a diagnostic viewpoint
  AKIO MORI, Kanagawa, Japan
• Chemokines and antichemokines in eosinophil activation
  BERNHARD HOMEY, Düsseldorf, Germany
• How do activated eosinophils react ?
• Anti-IL-5 versus Imatinib in the treatment of hypereosinophilic syndrome
  SABINE PLÖTZ, Munich, Germany

– 15.30 - 17.00

Mast Cell News

• Ontogeny of mast cells
• Signal transactions in mast cells
  SANTA J. ONO, London, United Kingdom
• Priming of mast cells and basophils
  CLEMENS DAHINDEN, Bern, Switzerland
• a and ß mast cell tryptases
  LAWRENCE SCHWARTZ, Richmond, United States

---

Jeudi 30 juin

Plenary Session

– 10.30 - 12.00

Allergy Affects the Whole Body

• The allergy "march" (marathon)
  ULRICH WAHN, Berlin, Germany
• Allergen-specific immunotherapy
  STEPHEN DURHAM, London, United Kingdom
• Allergen-independent immunotherapy
  ANDREW SAXON, Los Angeles, United States
• Allergy starts in the blood
  JUDAH A. DENBURG, Hamilton, Canada

World Allergy Forum (WAF) 13.30 - 15.00

Novel Approaches to Food Allergy

• Epidemiology and natural history of food allergy
• Diagnosis of food allergy
• Treatment of food allergy

Symposia

– 08.30 - 10.00

Primary Prevention of Allergy and Asthma

• WAO document on PAAA
  TARI HAATELA, Helsinki, Finland
• The hypoallergenic concept
  ARNE HØST, Odense, Denmark
• Tolerance induction by pro and prebiotics
  ERIKA ISOLAURI, Turku, Finland
• Possibilities and limitation for alimentary prevention of atopy and asthma
  SCOTT H. SICHERER, New York, United States

– 08.30 - 10.00

Contact Dermatitis

• Epidemiology of contact dermatitis
  THOMAS FUCHS, Goettingen, Germany
• Molecular nature of contact allergens
  JEAN-PIERRE LEPOITTEVIN, Strasbourg, France
• Protein contact dermatitis from rubber latex
  TIMO REUNALA, Tampere, Finland
• Prevention of contact dermatitis
  TORKIL MENNÉ, Copenhagen, Denmark

– 13.30 - 15.00

Junior Member Symposium Allergy : Nature or Nurture ?

• Allergy : Nature or nurture ?
  BART LAMBRECHT, Rotterdam, The Netherlands
• The role of infection in asthma and allergy
  ELISABETH BEL, Leiden, The Netherlands
• Lymphocyte activation
  KARIM VERMAELEN, Ghent, Belgium
• Neuromodulation and allergy
  ULRIKE RAAP, Hannover, Germany

– 13.30 - 15.00

Mast Cells in Action

• Heterogeneity of mast cells
  HIROHISA SAITO, Tokyo, Japan
• Mast cells as antigen presenting cells
  SALAH MÉCHERI, Paris, France
• TGFß and mast cell activation
  PETER HOWARTH, Southampton, United Kingdom
• Eosinophil-mast cell cross talk
  FRANCESCA LEVI-SCHAFFER, Jerusalem, Israel

– 13.30 - 15.00

Rhinitis

• Staphylococcal antigens and rhinitis
  CLAUS BACHERT, Ghent, Belgium
• Immunotherapy in rhinitis : does it prevent asthma ?
  GIOVANNI PASSALACQUA, Genoa, Italy
• Provocation tests in allergic rhinitis
  ALKIS TOGIAS, Baltimore, United States
• New approaches of rhinitis therapy
  RUBY PAWANKAR, Tokyo, Japan

– 13.30 - 15.00

Drug Reactions

• Betalactam cross-reactivities
  MIGUEL BLANCA, Malaga, Spain
• Diagnostic work-up in drug allergy
  PASCAL DEMOLY, Montpellier, France
• Toxic epidermal necrolysis
• Cutaneous reactions to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  MARIO SANCHEZ-BORGES, Caracas, Venezuela

– 15.30 - 17.00

Non-injective Immunotherapy

• IgE Regulation Introduction
  S.G.O. JOHANSSON, Stockholm, Sweden
• Memory and plasma cells in IgE formation
  ANDREAS RADBRUCH, Berlin, Germany
• Plasma cell markers for IgE synthesis
  LARS POULSEN, Copenhagen, Denmark
• IgE-IgE-receptor interaction and antagonists
  HANNAH GOULD, London, United Kingdom
• Anti-IgE therapy
  THOMAS CASALE, Omaha, United States

– 15.30 - 17.00

Allergy Education and Training all over the World

• Allergy education in Europe
  SERGIO G. DEL GIACCO, Cagliari, Italy
• Allergy education in USA
  LANNY ROSENWASSER, Denver, United States
• Allergy education in South-East Asia/Australia
  CONSTANCE KATELARIS, Westmead, Australia
• Allergy education in Latin America
  CARLOS CRISCI, Rosario, Argentina
• Allergy education in Africa
  CASSIM MOTALA, Cape Town, South Africa

– 15.30 - 17.00

Psyche, Nerves and Allergy

• The BRAIN study
  WILLIAM BUSSE,Madison, United States
• Mind-body interactions in allergy
  JOHN BIENENSTOCK, Hamilton, Canada
• Neurotrophins in asthma and allergy
  HARALD RENZ,Marburg, Germany
• NGF and allergy
  SERGIO BONINI, Rome, Italy

Workshops

– 08.30 - 10.00

Mast Cells and Mastocytosis

• Gene polymorphisms in mastocytosis
  KARIN HARTMAN, Cologne, Germany
• Which factors make mast cells release their mediators ?
• How to bring skin mast cells into culture ?
• The role of hyperosmolarity in mast cell activation
  MARIA KUMLIN, Stockholm, Sweden (TBC)
• Mast cell-nerve interactions
• Mast cells : The forgotten inflammatory cells in immunopathogenesis
  YOSEPH MEKORI, Kfar-Saba, Israel

– 08.30 - 10.00

Cough and Sputum

• Induced sputum in basic research
  ANTOINE MAGNAN, Marseille, France
• Induced sputum in basic asthma research
  PASCAL CHANEZ, Montepellier, France
• Induced sputum in clinical practice
  MARIA MARGARET MENEZES PIZZICHINI, Floranopolis, Brazil
• Use in clinical practice
  ANTONIO SPANEVELLO, Bari, Italy
• Induced sputum
  FREDERICK HARGREAVE, Hamilton, Canada
• Methods to collect induced sputum

– 13.30 - 15.00

Histamine is More than a Vaso-Active Mediator

• Histamine as immune regulator
  MAREK JUTEL,Wroclaw, Poland
• Histamine releasing factor, does it exist ?
• NO and histamine release
  PIER FRANSESCO MANNAIONI, Firenze, Italy (TBC)
• Histamine H4 receptor agonists
• Physiological role of mast cells and histamine
  MEIR SHALIT, Jerusalem, Israel

– 13.30 - 15.00

Chronic Rhinosinusitis : Answers to a Hot Topic

• Eosinophilic fungal rhinosinusitis
  JEAN SILVAIN LACROIX, Geneva, Switzerland
• New treatment options
• Anti-eotaxin treatment
  GLENIS SCADDING, London, United Kingdom
• EB treatment of CRS
  WYTSKE FOKKENS, Amsterdam, The Netherlands
• Remodelling and wound healing in CRS
  JEAN-BAPTISTE WATELET, Gent, Belgium

– 15.30 - 17.00

Sports and Allergy

• Sports and asthma
  TARI HAATHELA, Helsinki, Finland
• Risk of sports for allergic individuals
  LUIS DELGADO, Porto, Portugal
• Positive effect of sports in allergy
  KAI-HÅKON CARLSEN, Oslo, Norway
• Sports therapy programs for asthmatics
  CONSTANCE KATELARIS,Westmead, Australia (TBC)
• Pharmacotherapy of asthma in sport people

---

Vendredi 1er Juillet

Plenary Session

– 10.30 - 12.00

Allergy May be a Killer

• Pathophysiology of anaphylaxis
  STEPHEN GALLI, Stanford, United States
• Epidemiology and risk factors for anaphylaxis
  DANIEL VERVLOET, Marseille, France
• Management and treatment of anaphylaxis
  F ESTELLE R SIMONS, Winnipeg, Canada
• Near fatal asthma

Symposia

– 08.30 - 10.00

The Burden of Asthma

• Socioeconomic aspects of asthma
  RICHARD BEASLEY,Wellington, New Zealand
• Quality of Life in asthma
• The cost of asthma /education
  FRANCISCO NUNEZ, Porto Salvo, Portugal (TBC)
• Asthma mortality worldwide
  HUGO NEFFEN, Santa Fe, Argentina
• Unmet needs in asthma
  SALLY WENZEL, Denver, United States

– 13.30 - 15.00

Perspectives of Immunotherapy

• Adjuvants in immunotherapy
  PETER CRETICOS, Baltimore, United States
• Peptides in immunotherapy
  MARK LARCHÉ, London, United Kingdom
• Latex immunotherapy
  FLORIANO BONIFAZI, Torrette - Ancona, Italy
• DNA vaccination strategies
  WOLF-MEINHARD BECKER, Borstel, Germany

– 13.30 - 15.00

Anaphylaxis

• New concepts in anaphylaxis
  RICHARD F. LOCKEY, Tampa, United States
• Management of anaphylaxis in nut allergy
  PAMELA EWAN, Cambridge, United Kingdom
• Basic aspects of anaphylaxis
  TODOR POPOV, Sofia, Bulgaria
• Radiographic contrast media reactions
  PHIL LIEBERMANN, Germanstown, United States

– 13.30 - 15.00

New Diagnostic Techniques

• Antibody detection techniques
  ROBERT AALBERSE, Amsterdam, The Netherlands
• Chip array techniques
  HANS MERK/Co-author : JENS MALTE BARON, Aachen, Germany
• In vitro basophil techniques
  IGNACIO JAVIER ANSOTEGUI, Amorebieta, Spain
• NO + exhaled broncholysate measurements for asthma control
  M. CRACA CASTEL-BRANCO, Saõ Mamede do Coronado Portugal

Workshops

– 08.30 - 10.00

What Molecules are Involved in the Formation of IgE Antibodies ?

• Il-4 or IL-13-inducible genes in bronchial epithelial cells
  KENJI IZUHARA, Saga, Japan
• Signal transduction in IgE synthesis
  GERNOT ACHATZ, Salzburg, Austria (TBC)
• Regulation of STAT6 by members of the SOCS family
  ALBERT DUSCHL, Salzburg, Austria
• MHC restriction of IgE response
• Basic mechanisms of anti-IgE treatment
  BEDA STADLER, Bern, Switzerland
• Soluble CD23 as IgE synthesis inhibitor

– 08.30 - 10.00

Controversies in Paediatric Allergy II : Anti-inflammatory Therapy in Wheezy Infants - Yes or No ?

• Preschool children asthma
  NELSON ROSARIO, Curitiba, Brazil
• Alternative treatments in allergy
  TORSTEN SCHAEFER, Lübeck, Germany
• Risk factors for allergy in childhood
  MARIO MORAIS ALMEIDA, Lisbon, Portugal (TBC)
• At what age to start with inhaled glucocorticosteroids ?
• Do children with asthma benefit from antihistamine ?

– 08.30 - 10.00

Current Problems in Insect Venom Allergy

• Venom immunotherapy : when and how to start
  JÖELLE BIRNBAUM, Marseille, France
• Venom immunotherapy : when and how to end ?
• Mastocytosis : an indication for life-long venom immunotherapy
  BERHARD PRZYBILLA, Munich, Germany
• Are ß-blockers a true contraindication for immunotherapy ?
  ULRICH MÜLLER, Bern, Switzerland
• How common and dangerous is bumblebee allergy ?
  HANS DE GROOT, Rotterdam, The Netherlands

– 08.30 - 10.00

Cross Reactive Foods :

• Minor Inconvenience or Serious Problem Molecular nature of food allergen epitopes as basis of cross-reactivity
  KIRSTEN BEYER, Berlin, Germany
• Latex-fruit syndrome
  BARBARA BALLMER-WEBER, Zürich, Switzerland
• Evaluation by history of cross-reactive food allergens
  MARIA ISABEL CARRAPATOSO, Coimbra, Spain
• Apple as a model of cross-reacting food allergens
  KARIN HOFFMANN-SOMMERGRUBER, Vienna, Austria
• Composite allergens in plants and foods
  JASNA LIPOZENCIC, Zagreb, Croatia

– 13.30 - 15.00

Outdoor Air Pollution and Allergy : Myth or Fact and What to Do ?

• Diesel exhaust particles and allergy
  DAVID DIAZ-SANCHEZ, Los Angeles, United States
• High frequency radio and mobile phone radiation and human disease
  DENIS NOWAK, Munich, Germany
• Particles, ozone and bronchial response
  DAVID PEDEN, Chapel Hill, United States
• Xenobiotic metabolism of PAHs : role in adjuvant activity for allergic disease
  JEROME BUTERS, Munich, Germany
• Air pollution in big cities and allergy

– 13.30 - 15.00

Atopic Eczema :

• What are the Individual Provocation Factors ? Does Malassezia contribute to atopic eczema
  ANNIKA SCHEYNIUS, Stockholm, Sweden
• Fungal SOD in atopic eczema
  PETER SCHMID-GRENDELMEIER, Zürich, Switzerland
• Atopy patch test : the most specific diagnostic tool in eczema
  ULF DARSOW, Munich, Germany
• APT with native foods in children and adults
  KRISTIINA TURJANMAA, Tampere, Finland
• Staphylococcal infection /colonization : does it play a role in eczema ?
  MARK BOGUNIEWICZ, Denver, United States
• Phosphodiesterase in atopic eczema